Acne
Conditions
Interventions
Group A:DUO+ treatment alone
Group B:Duo+ combined with BPO treatment
Group C:BPO treatment alone
Sponsors
Shanghai Dermatology Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Adults 18~35 years old; 2.Facial skin lesions, mainly in patients with acne vulgaris, mild to moderate; 3.Mainly manifested as acne and inflammatory papules; 4.The patients voluntarily participated in clinical observation and signed an informed consent form. Willing to cooperate with follow-up observation. Have good communication and understanding skills.
Exclusion criteria
Exclusion criteria: 1. Patients with severe acne with pustules, cysts, nodules and other skin lesions on the face; 2. Other drugs and treatments for external use within one month; 3. Systematic treatment within three months (retinoic acid drugs and photodynamics within 6 months); 4. Use topical acne treatment drugs or functional skin care products one week before enrollment; 5. The affected area is complicated by other skin diseases that may obviously affect the efficacy evaluation; 6. Related diseases treated with female patients using estrogen or estrogen-like hormones; 7. Those who have a history of allergies to the medicines and ingredients used this time; 8. People with severe heart, brain, lung, liver, and kidney damage; 9. Pregnant women, breastfeeding women; 10. People with a history of psychological and mental illness, recent history of alcohol or drug abuse; 11. Patients who are unwilling to sign informed consent, and those who are unwilling to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Changes in the number and severity of acne and inflammatory papules; | — |
Secondary
| Measure | Time frame |
|---|---|
| Erythema after inflammation;Melanin;Transdermal water loss; | — |
Countries
China
Contacts
Public ContactShen Zhong
L'Oreal (China) Co., Ltd.
Outcome results
None listed